Physician profile
Michael Nizzi
NPI 1700802055
$10,176.26
in general payments reported to CMS, 2019-2025
13 companies · $159 in 2025
The $159 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,827 · 2020: $213 · 2021: $4,275 · 2022: $83.71 · 2023: $280 · 2024: $338 · 2025: $159.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $762 · Education: $15.22.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $761.65 |
| Education | $15.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $8,799.67 | 2019-2025 | |
| W. L. Gore & Associates, INC. | $469.07 | 2020-2024 | Gore Synecor Biomaterial, Seamguard |
| Tela Bio, INC. | $316.97 | 2023-2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Conmed Corporation | $213.66 | 2024 | Conmed Handheld Instruments, Airseal, Visiclear |
| Ethicon US, LLC | $150.23 | 2019-2020 | |
| Smith+Nephew, INC. | $52.38 | 2019-2023 | Renasys Touch |
| Braintree Laboratories, INC. | $34.23 | 2021-2023 | Sutab, Suflave |
| Davol INC. | $31.88 | 2019-2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $30.44 | 2022-2023 | Gattex |
| Ferring Pharmaceuticals INC. | $26.06 | 2020 | |
| Integra Lifesciences Corporation | $23.91 | 2022 | |
| Convatec INC. | $14.77 | 2020 | |
| Boston Scientific Corporation | $12.99 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Nizzi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.